IFG Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$969K Buy
837
+17
+2% +$20.1K 0.13% 76
2026
Q2
$984K Buy
820
+2
+0.2% +$2.04K 0.14% 76
2026
Q1
$752K Buy
818
+13
+2% +$13.2K 0.12% 76
2025
Q4
$865K Hold
805
– – 0.14% 68
2025
Q3
$614K Hold
805
– – 0.1% 80
2025
Q2
$628K Buy
805
+1
+0.1% +$777 0.11% 78
2025
Q1
$664K Hold
804
– – 0.13% 74
2024
Q4
$621K Sell
804
-57
-7% -$47.2K 0.12% 75
2024
Q3
$763K Buy
861
+66
+8% +$59.3K 0.16% 58
2024
Q2
$720K Hold
795
– – 0.17% 59
2024
Q1
$618K Buy
795
+65
+9% +$46.3K 0.16% 63
2023
Q4
$426K Buy
730
+76
+12% +$44.4K 0.12% 76
2023
Q3
$351K Hold
654
– – 0.12% 83
2023
Q2
$307K Buy
654
+24
+4% +$10.1K 0.11% 94
2023
Q1
$216K Hold
630
– – 0.09% 114
2022
Q4
$230K Hold
630
– – 0.1% 107
2022
Q3
$204K Buy
+630
New +$200K 0.1% 100

Other funds holding LLY

IFG Advisors's LLY Position: Q3 2026 in Review

IFG Advisors increased its Eli Lilly (LLY) stake by 2.1% in Q3 2026, buying an estimated $20.1K and bringing the position to 837 shares worth $969K. The position accounts for 0.13% of the portfolio, ranked #76.

IFG Advisors first reported a position in LLY in Q3 2022 and has held it in 17 quarters since. The position peaked at $984K in Q2 2026. 3,244 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • IFG Advisors held 837 shares of Eli Lilly worth $969K as of Q3 2026.
  • IFG Advisors bought 17 Eli Lilly shares in Q3 2026, an estimated $20.1K.
  • Eli Lilly made up 0.13% of IFG Advisors's portfolio in Q3 2026, its #76 holding.
  • IFG Advisors first reported a position in Eli Lilly in Q3 2022 and has held it in 17 quarters since.
  • IFG Advisors's Eli Lilly position peaked at $984K in Q2 2026.
  • 3,244 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on IFG Advisors's 13F filing for Q3 2026, filed 15 Oct 2026.